Bristol Myers Squibb has filed a lawsuit against the Biden administration for blocking the company from using rebates to pay hospitals in a federal drug discount program. This is the fourth pharmaceutical company to challenge payment terms recently. The lawsuit specifically involves Bristol’s Eliquis blood thinner. The U.S. Department of Health and Human Services rejected similar requests from Johnson & Johnson and Eli Lilly, who also filed lawsuits. Bristol argues that the 340B Drug Discount Program, created to assist hospitals caring for low-income patients, is wasteful and abusive. Companies participating in Medicare or Medicaid must offer discounts on their medicines to participating hospitals and clinics.
Source link
Bristol Myers is latest company to sue over payment terms for 340B hospitals
